June 2026
The global small molecule innovator CDMO market size is valued at USD 56.41 billion in 2025 and is projected to hit around USD 103.22 billion by 2035 with a CAGR of 6.23%.
June 2026
The global synthetic small molecule API market size is estimated to hit around USD 342.63 billion by 2035 increasing from USD 197.21 billion in 2025, with a CAGR of 5.68%.
June 2026
The global small molecule API market size was valued at USD 205.69 billion in 2025 and is projected to surpass around USD 347.45 billion by 2035 with a CAGR of 5.38%.
January 2026
The global small molecule drug discovery market size is calculated at USD 95.63 billion in 2025 and is projected to hit around USD 204.06 billion by 2035 with a CAGR of 7.87%.
January 2026
The global small molecule immunomodulators market size is projected to hit around USD 339.54 billion by 2035 from USD 187.09 billion by 2025, at a CAGR of 6.14%.
December 2025
The global outsourced small-molecule API manufacturing market grows as pharma companies partner with CDMOs for cost-efficient, scalable, and compliant API production.t
September 2025
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The global sterile injectables CDMO market size is estimated to hit around USD 11.82 billion by 2035 from USD 4.73 billion in 2025, with a CAGR of 9.59%.
June 2026
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
June 2026
The global pharmaceutical CDMO for formulations market size is accounted to hit around USD 103.33 billion by 2035, increasing from USD 48.85 billion in 2025, with a CAGR of 7.78%.
June 2026
The global AI-integrated CDMO process optimization market is growing as contract manufacturers adopt AI to streamline drug development and manufacturing workflows.
June 2026
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
June 2026
The global small nuclear reactor market size was evaluated at USD 7.49 billion in 2025 and is predicted to hit around USD 17.37 billion by 2035, growing at a CAGR of 8.78%.
May 2026
The global small hydropower market size was evaluated at USD 2.33 billion in 2025 and is projected to surpass around USD 3.07 billion by 2035 with a CAGR of 2.80%.
May 2026
Europe Pharmaceutical CDMO market size is projected to hit around USD 94.94 billion by 2035, rising from USD 45.68 billion in 2025, growing at a CAGR of 7.59%.
May 2026
The global active pharmaceutical ingredients CDMO market size is evaluated at USD 116.77 billion in 2025 and is predicted to hit around USD 231.48 billion by 2035, growing at a CAGR of 7.81%.
May 2026
The global large molecule drug discovery outsourcing market size was evaluated at USD 3.20 billion in 2025 and is predicted to hit around USD 7.67 billion by 2035, growing at a CAGR of 9.14%.
April 2026
The global chemical drug CDMO market size was evaluated at USD 13.20 billion in 2025 and is predicted to hit around USD 29.84 billion by 2035, growing at a CAGR of 8.50%.
April 2026
The global chemical API CDMO market size was evaluated at USD 16.80 billion in 2025 and is predicted to hit around USD 40.88 billion by 2035, growing at a CAGR of 9.30%.
April 2026
The global small-scale LNG market size was evaluated at USD 68.50 billion in 2025 and is expected to attain around USD 250.63 billion by 2035, with a CAGR of 13.85%.
April 2026
The global mRNA therapeutics CDMO market size is estimated to hit around USD 14.63 billion by 2035 from USD 5.09 billion in 2025, with a CAGR of 11.14%.
March 2026
The nuclear small modular reactors (SMRs) market is expanding with rising demand for clean, safe, and flexible nuclear power solutions.
March 2026
The small caliber ammunition market size is evaluated at USD 10.31 billion in 2025 and is expected to hit around USD 15.08 billion by 2035 with a CAGR of 3.77%.
March 2026
The global small modular reactor market size valued at USD 7.49 billion in 2025 and it is expected to hit around USD 17.37 billion by 2035 at a CAGR of 8.78%.
March 2026
The global live biotherapeutic products and microbiome CDMO market size is estimated to hit around USD 1,838.56 million by 2035 from USD 76.77 million in 2025, at a CAGR of 37.38%.
March 2026
The hormonal drug CDMO market is expanding with rising demand for outsourced development and manufacturing of therapies for endocrine and reproductive health.
March 2026
The global bispecific antibodies CDMO market expands with demand for next-generation therapeutics, advanced expression systems, and regulatory compliance expertise.
March 2026
The global pharmaceutical CDMO market size is calculated at USD 197.40 billion in 2025 and is projected to hit around USD 392.67 billion by 2035 with a CAGR of 7.12%.
February 2026
The global metastatic non-small cell lung cancer market size was evaluated at USD 18.50 billion in 2025 and is predicted to hit around USD 50.30 billion by 2035, growing at a CAGR of 10.52%.
February 2026
The global biologics CDMO market size was valued at USD 23.08 billion in 2025 and is projected to hit around USD 55.11 billion by 2035 with a healthy CAGR of 9.14%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com